Abstract
Introduction The testing of infected persons with SARS-CoV-2 is one of the cornerstones to deploy pandemic control strategies. The public diagnostic effort is particularly important among the most vulnerable socioeconomic districts, such as São Paulo state, the Brazilian epicenter of the COVID-19 pandemic.
Methods We developed an RT-PCR testing intensity effort index (RT-PCR TIEI) composed of seven indicators to assess the intensity testing efforts in the state of São Paulo. We used dynamic time-series cross-sectional models to analyze the association between the RT-PCR TIEI in São Paulo state, the proportion of the population living under a high socioeconomic vulnerability level, dependent on public health service (SUS), per capita income, and population density.
Results On average, the RT-PCR TIEI score was 23.50. The maximum (47.06) was reached in week 11 and declined in subsequent weeks. The lowest score (17.65) was reached in week 25. In the long-run, the RT-PCR TIEI is negatively associated with socioeconomic vulnerability (p-value=0.000, 95% CI -0.896, -0.816), with a higher proportion of the population dependent on SUS (p-value= 0.000, 95% CI -0.877, 0.808) and with population density (p-value=0.000, 95% CI -0.857; -0.806).
Conclusion There was a decline in the state’s testing intensity as the pandemic advanced, and the most socioeconomic vulnerable RHDs showed the lowest values where local public laboratory presence is a predictor of a higher RT-PCR TIEI score. Thus, the low testing RT-PCR effort and local laboratory inequality affect surveillance capability, especially for the most socioeconomic vulnerable population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research fellowships were provided by the Institutos Betty e Jacob Lafer, Tide Setubal, and Cebrap. N.M. received a research grant from the Sao Paulo Research Foundation (FAPESP) - (2016/13199-8).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Since all data used in this manuscript are provided by open access source the IRB and/or ethics committee approvals is not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.